GLP1R and Parkinson disease: SCFAs play a beneficial role in PD by stimulating GLP-1 secretion, ameliorating PD-associated mouse behaviors, preventing DA neuron death, and restoring reduced tight junction protein levels induced by MPTP toxicity [14].